OBJECTIVE: Our goal was to test the hypothesis that the previously demonstr
ated progesterone-independent prolongation of pregnancy in rats treated wit
h cervical application of the cyclooxygenase 2 inhibitor nimesulide is the
result of inhibition of cervical ripening.
STUDY DESIGN: Timed-pregnant Sprague-Dawley rats were randomly allocated to
treatment with 50 mg nimesulide or vehicle, applied daily on the cervix fo
r 5 days (days 14-18). On day 19 the animals were humanely killed and the c
ervices were removed. In the first series of experiments the cervices of an
imals treated with nimesulide (n = 10) or vehicle (n = 10) were examined wi
th a cervimeter, which stretches the cervical tissues in incremental steps
of 0.2 mm at 1-minute intervals. A steeper slope through the linear portion
of the resulting force-versus-displacement curve indicates more resistance
to stretch. In the second series of experiments the cervices of animals tr
eated with nimesulide (n = 11) or vehicle (n = 11) were examined with the C
ollascope optical device. The cervical content of cross-linked collagen was
measured with light-induced fluorescence. The fluorescence spectrum at 390
nm (peak wavelength of the collagen spectrum) was determined. For standard
ization, the ratio of counts of collagen peak over reference counts was use
d in the final analyses as an indicator of cross-linked collagen content.
RESULTS: Animals treated with cervical application of nimesulide had signif
icantly higher resistance to stretch than controls (slope: 0.2564 +/- 0.121
3 vs 0.1387 +/- 0.0652; P = 0.019). The cervical content of crosslinked col
lagen was not significantly different between nimesulide-treated animals an
d controls (light-induced fluorescence ratios: 3.2134 +/- 0.7390 vs 2.7892
+/- 0.8518; P = .227).
CONCLUSIONS: Treatment with cervical application of the cyclooxygenase 2 in
hibitor nimesulide prevents the physiologic process of cervical ripening in
late pregnancy. The inhibition is not the result of changes in cross-linke
d collagen content. Inhibition of cervical ripening with locally administer
ed cyclooxygenase 2 inhibitor may be a potentially valuable treatment for p
atients at risk for preterm delivery.